Fertility drugs and malignant germ-cell tumour of ovary in pregnancy

Lancet

Volumn 351, Issue 9107, 1998, Pages 957-958

  Tewari, Krishnansu ^b   Rose, G Scott ^b   Balderston, Keith D ^b   Porto, Manuel ^b   Kohler, Matthew F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CLOMIFENE CITRATE; FOLLITROPIN; GONADORELIN;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FEMALE INFERTILITY; GERM CELL TUMOR; HUMAN; OVARY CANCER; OVARY TERATOMA; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL;

EID: 0032495653     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60612-5     Document Type: Article

References (4)

1. 1 Whittemore AS, Harris R, Itnyre J, and the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case-control studies II, invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184-203.
2. 2 Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-76.
3. 3 Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995-1000.
4. 4 Willemsen W, Kruitwagen R, Bastiaans B, Hanselaar T, Rolland R. Ovarian stimulation and granulosa-cell tumour. Lancet 1993; 341: 986-88.